Published in Med Care on June 01, 2009
Overuse of screening colonoscopy in the Medicare population. Arch Intern Med (2011) 3.08
Assessing the impact of screening colonoscopy on mortality in the medicare population. J Gen Intern Med (2011) 1.73
Canadian guidelines for clinical practice: an analysis of their quality and relevance to the care of adults with comorbidity. BMC Fam Pract (2011) 1.52
How applicable are clinical practice guidelines to elderly patients with comorbidities? Can Fam Physician (2011) 1.51
Management of human immunodeficiency virus infection in advanced age. JAMA (2013) 1.51
A framework for crafting clinical practice guidelines that are relevant to the care and management of people with multimorbidity. J Gen Intern Med (2014) 1.46
Frailty in primary care: a review of its conceptualization and implications for practice. BMC Med (2012) 1.32
The next therapeutic challenge in HIV: polypharmacy. Drugs Aging (2013) 1.30
Cancer screening in patients infected with HIV. Curr HIV/AIDS Rep (2011) 1.21
The Ariadne principles: how to handle multimorbidity in primary care consultations. BMC Med (2014) 1.13
Lag time to benefit for preventive therapies. JAMA (2014) 0.98
Prostate cancer: modeling the outcomes of prostate cancer screening. Nat Rev Urol (2012) 0.87
Cost-effectiveness of pneumococcal conjugate vaccination in immunocompromised adults. Vaccine (2013) 0.86
Patient-centered care for people living with multimorbidity. Curr Opin HIV AIDS (2014) 0.82
How GPs value guidelines applied to patients with multimorbidity: a qualitative study. BMJ Open (2015) 0.81
What is the Best Way to Produce Consensus and Buy in to Guidelines for Rectal Cancer? Curr Colorectal Cancer Rep (2012) 0.76
Comorbidities, frailty, and "pay-off time". Med Care (2009) 0.75
Using the Payoff Time in Decision-Analytic Models: A Case Study for Using Statins in Primary Prevention. Med Decis Making (2017) 0.75
Evaluating the Implementation and Feasibility of a Web-Based Tool to Support Timely Identification and Care for the Frail Population in Primary Healthcare Settings. Int J Health Policy Manag (2017) 0.75
Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. JAMA (2005) 20.53
Primary care: is there enough time for prevention? Am J Public Health (2003) 15.81
Cancer screening in elderly patients: a framework for individualized decision making. JAMA (2001) 9.79
Potential pitfalls of disease-specific guidelines for patients with multiple conditions. N Engl J Med (2004) 7.82
Development and validation of a prognostic index for 4-year mortality in older adults. JAMA (2006) 6.79
The Seattle Heart Failure Model: prediction of survival in heart failure. Circulation (2006) 6.58
PSA screening among elderly men with limited life expectancies. JAMA (2006) 5.70
Estrogen plus progestin and colorectal cancer in postmenopausal women. N Engl J Med (2004) 5.65
Physical activity, obesity, and risk for colon cancer and adenoma in men. Ann Intern Med (1995) 5.42
Diabetes mellitus and risk of colorectal cancer: a meta-analysis. J Natl Cancer Inst (2005) 5.32
Frailty in relation to the accumulation of deficits. J Gerontol A Biol Sci Med Sci (2007) 5.20
Complications of colonoscopy in an integrated health care delivery system. Ann Intern Med (2006) 5.10
The use of aspirin for primary prevention of colorectal cancer: a systematic review prepared for the U.S. Preventive Services Task Force. Ann Intern Med (2007) 4.74
A systematic review and meta-analysis of familial colorectal cancer risk. Am J Gastroenterol (2001) 4.61
Reconsidering medication appropriateness for patients late in life. Arch Intern Med (2006) 3.81
Increased risk of rectal cancer after prostate radiation: a population-based study. Gastroenterology (2005) 3.58
Alcohol intake and colorectal cancer: a pooled analysis of 8 cohort studies. Ann Intern Med (2004) 3.18
Using clinical guidelines designed for older adults with diabetes mellitus and complex health status. JAMA (2006) 2.98
Frailty, hospitalization, and progression of disability in a cohort of disabled older women. Am J Med (2005) 2.74
A convenient approximation of life expectancy (the "DEALE"). I. Validation of the method. Am J Med (1982) 2.49
Leisure-time physical activity, body size, and colon cancer in women. Nurses' Health Study Research Group. J Natl Cancer Inst (1997) 2.46
Long-term solid cancer risk among 5-year survivors of Hodgkin's lymphoma. J Clin Oncol (2007) 2.17
A framework for tailoring clinical guidelines to comorbidity at the point of care. Arch Intern Med (2007) 1.92
The prevalence of colonic polyps in acromegaly: a colonoscopic and pathological study in 103 patients. J Clin Endocrinol Metab (1995) 1.68
Comparing risks and benefits of colorectal cancer screening in elderly patients. Gastroenterology (2005) 1.65
The frailty syndrome: a critical issue in geriatric oncology. Crit Rev Oncol Hematol (2003) 1.58
Instrumental activities of daily living as a potential marker of frailty: a study of 7364 community-dwelling elderly women (the EPIDOS study). J Gerontol A Biol Sci Med Sci (2001) 1.47
The influence of year-end bonuses on colorectal cancer screening. Am J Manag Care (2004) 1.01
Colorectal cancer screening in young patients with poor health and severe comorbidity. Arch Intern Med (2006) 0.99
Lifetime cigarette smoking and colorectal cancer incidence in the Physicians' Health Study I. J Natl Cancer Inst (2000) 0.98
In the clinic. Colorectal cancer screening. Ann Intern Med (2008) 0.86
Effect of early versus deferred antiretroviral therapy for HIV on survival. N Engl J Med (2009) 19.90
Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. Lancet (2002) 16.56
Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies. Lancet (2009) 14.01
HIV infection and the risk of acute myocardial infarction. JAMA Intern Med (2013) 5.90
HIV treatment response and prognosis in Europe and North America in the first decade of highly active antiretroviral therapy: a collaborative analysis. Lancet (2006) 5.00
Aging and infectious diseases: workshop on HIV infection and aging: what is known and future research directions. Clin Infect Dis (2008) 4.46
Prognosis of HIV-1-infected patients up to 5 years after initiation of HAART: collaborative analysis of prospective studies. AIDS (2007) 4.31
Development and verification of a "virtual" cohort using the National VA Health Information System. Med Care (2006) 4.28
Late presentation for human immunodeficiency virus care in the United States and Canada. Clin Infect Dis (2010) 3.72
Cohort profile: the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD). Int J Epidemiol (2007) 3.46
A temporal and dose-response association between alcohol consumption and medication adherence among veterans in care. Alcohol Clin Exp Res (2005) 3.21
Aging and infectious diseases: do patterns of comorbidity vary by HIV status, age, and HIV severity? Clin Infect Dis (2007) 3.02
HIV infection and risk for incident pulmonary diseases in the combination antiretroviral therapy era. Am J Respir Crit Care Med (2010) 3.00
HIV and aging: state of knowledge and areas of critical need for research. A report to the NIH Office of AIDS Research by the HIV and Aging Working Group. J Acquir Immune Defic Syndr (2012) 2.95
Increased COPD among HIV-positive compared to HIV-negative veterans. Chest (2006) 2.93
The impact of cigarette smoking on mortality, quality of life, and comorbid illness among HIV-positive veterans. J Gen Intern Med (2005) 2.58
Relative prevalence of comorbidities and treatment contraindications in HIV-mono-infected and HIV/HCV-co-infected veterans. AIDS (2005) 2.56
Risk of anal cancer in HIV-infected and HIV-uninfected individuals in North America. Clin Infect Dis (2012) 2.50
Estimating the proportion of patients infected with HIV who will die of comorbid diseases. Am J Med (2005) 2.38
Rate and predictors of treatment prescription for hepatitis C. Gut (2006) 2.31
Development and validation of a prognostic model for survival time data: application to prognosis of HIV positive patients treated with antiretroviral therapy. Stat Med (2004) 2.26
Relationship between alcohol use categories and noninvasive markers of advanced hepatic fibrosis in HIV-infected, chronic hepatitis C virus-infected, and uninfected patients. Clin Infect Dis (2014) 2.24
Adherence, virological and immunological outcomes for HIV-infected veterans starting combination antiretroviral therapies. AIDS (2007) 2.24
U.S. trends in antiretroviral therapy use, HIV RNA plasma viral loads, and CD4 T-lymphocyte cell counts among HIV-infected persons, 2000 to 2008. Ann Intern Med (2012) 2.18
Understanding racial disparities in HIV using data from the veterans aging cohort 3-site study and VA administrative data. Am J Public Health (2003) 2.16
How harmful is hazardous alcohol use and abuse in HIV infection: do health care providers know who is at risk? J Acquir Immune Defic Syndr (2003) 2.14
Increased risk of fragility fractures among HIV infected compared to uninfected male veterans. PLoS One (2011) 2.11
Hepatitis C treatment completion rates in routine clinical care. Liver Int (2009) 2.10
HIV infection and the risk of diabetes mellitus. AIDS (2009) 2.10
Hepatitis C virus infection and the risk of coronary disease. Clin Infect Dis (2009) 2.10
Incidence of non-AIDS-defining malignancies in HIV-infected versus noninfected patients in the HAART era: impact of immunosuppression. J Acquir Immune Defic Syndr (2009) 2.09
Risk of heart failure with human immunodeficiency virus in the absence of prior diagnosis of coronary heart disease. Arch Intern Med (2011) 2.08
Trends in multidrug treatment failure and subsequent mortality among antiretroviral therapy-experienced patients with HIV infection in North America. Clin Infect Dis (2009) 2.05
Spirituality and religion in patients with HIV/AIDS. J Gen Intern Med (2006) 1.99
Risk of diabetes in HIV infected veterans pre- and post-HAART and the role of HCV coinfection. Hepatology (2004) 1.97
A framework for tailoring clinical guidelines to comorbidity at the point of care. Arch Intern Med (2007) 1.92
Cumulative Incidence of Cancer Among Persons With HIV in North America: A Cohort Study. Ann Intern Med (2015) 1.86
Prognostic importance of anaemia in HIV type-1-infected patients starting antiretroviral therapy: collaborative analysis of prospective cohort studies. Antivir Ther (2008) 1.83
Validity of diagnostic codes and liver-related laboratory abnormalities to identify hepatic decompensation events in the Veterans Aging Cohort Study. Pharmacoepidemiol Drug Saf (2011) 1.76
Impact of cigarette smoking on mortality in HIV-positive and HIV-negative veterans. AIDS Educ Prev (2009) 1.72
Medical ICU admission diagnoses and outcomes in human immunodeficiency virus-infected and virus-uninfected veterans in the combination antiretroviral era. Crit Care Med (2013) 1.71
Validating smoking data from the Veteran's Affairs Health Factors dataset, an electronic data source. Nicotine Tob Res (2011) 1.69
An internationally generalizable risk index for mortality after one year of antiretroviral therapy. AIDS (2013) 1.64
Hepatic decompensation in antiretroviral-treated patients co-infected with HIV and hepatitis C virus compared with hepatitis C virus-monoinfected patients: a cohort study. Ann Intern Med (2014) 1.64
Impact of pneumococcal vaccination on the incidence of pneumonia by HIV infection status among patients enrolled in the Veterans Aging Cohort 5-Site Study. Clin Infect Dis (2008) 1.62
The risk of incident coronary heart disease among veterans with and without HIV and hepatitis C. Circ Cardiovasc Qual Outcomes (2011) 1.62
Clinical importance of HIV and depressive symptoms among veterans with HIV infection. J Gen Intern Med (2002) 1.57
Influence of alternative thresholds for initiating HIV treatment on quality-adjusted life expectancy: a decision model. Ann Intern Med (2008) 1.55
Do benefits of earlier antiretroviral treatment initiation outweigh harms for individuals at risk for poor adherence? Clin Infect Dis (2009) 1.54
Management of human immunodeficiency virus infection in advanced age. JAMA (2013) 1.51
Long-term HIV/AIDS survival estimation in the highly active antiretroviral therapy era. Med Decis Making (2003) 1.49
How does depression influence diabetes medication adherence in older patients? Am J Geriatr Psychiatry (2005) 1.46
Hepatocellular carcinoma and non-Hodgkin's lymphoma: the roles of HIV, hepatitis C infection, and alcohol abuse. J Clin Oncol (2006) 1.44
Smoking and life expectancy among HIV-infected individuals on antiretroviral therapy in Europe and North America. AIDS (2015) 1.44
Alcohol problems and health care services use in human immunodeficiency virus (HIV)-infected and HIV-uninfected veterans. Med Care (2006) 1.41
Association of age and comorbidity with physical function in HIV-infected and uninfected patients: results from the Veterans Aging Cohort Study. AIDS Patient Care STDS (2011) 1.37
Food insecurity is associated with poor virologic response among HIV-infected patients receiving antiretroviral medications. J Gen Intern Med (2011) 1.37
Virologic and immunologic response to HAART, by age and regimen class. AIDS (2010) 1.34
Differences between infectious diseases-certified physicians and general medicine-certified physicians in the level of comfort with providing primary care to patients. Clin Infect Dis (2005) 1.33
The burden of illness in the first year home: do male and female VA users differ in health conditions and healthcare utilization. Womens Health Issues (2010) 1.33
Delayed presentation for human immunodeficiency virus (HIV) care among veterans: a problem of access or screening? Med Care (2007) 1.32
The next therapeutic challenge in HIV: polypharmacy. Drugs Aging (2013) 1.30
Testing, referral, and treatment patterns for hepatitis C virus coinfection in a cohort of veterans with human immunodeficiency virus infection. Clin Infect Dis (2003) 1.29
Treatment outcomes of a stage 1 cognitive-behavioral trial to reduce alcohol use among human immunodeficiency virus-infected out-patients in western Kenya. Addiction (2011) 1.29
Role of alcohol in determining human immunodeficiency virus (HIV)-relevant outcomes: A conceptual model to guide the implementation of evidence-based interventions into practice. Med Care (2006) 1.28
Effect of persistent moderate viremia on disease progression during HIV therapy. J Acquir Immune Defic Syndr (2004) 1.27
Physiologic frailty and fragility fracture in HIV-infected male veterans. Clin Infect Dis (2013) 1.26
The association between alcohol consumption and prevalent cardiovascular diseases among HIV-infected and HIV-uninfected men. J Acquir Immune Defic Syndr (2010) 1.25
Long-term mortality in HIV-positive individuals virally suppressed for >3 years with incomplete CD4 recovery. Clin Infect Dis (2014) 1.25
Risk factors for hospitalization and medical intensive care unit (MICU) admission among HIV-infected Veterans. J Acquir Immune Defic Syndr (2013) 1.23
Patterns of drug use and abuse among aging adults with and without HIV: a latent class analysis of a US Veteran cohort. Drug Alcohol Depend (2010) 1.23
Adjusting alcohol quantity for mean consumption and intoxication threshold improves prediction of nonadherence in HIV patients and HIV-negative controls. Alcohol Clin Exp Res (2008) 1.23
Differences in symptom expression in older HIV-positive patients: The Veterans Aging Cohort 3 Site Study and HIV Cost and Service Utilization Study experience. J Acquir Immune Defic Syndr (2003) 1.21
Decreased awareness of current smoking among health care providers of HIV-positive compared to HIV-negative veterans. J Gen Intern Med (2007) 1.19
Association of venous thromboembolism with human immunodeficiency virus and mortality in veterans. Am J Med (2004) 1.19
An experimental study of the agreement of self-administration and telephone administration of the Timeline Followback interview. J Stud Alcohol Drugs (2008) 1.18
Measuring performance directly using the veterans health administration electronic medical record: a comparison with external peer review. Med Care (2007) 1.15
A comparison of two approaches to text processing: facilitating chart reviews of radiology reports in electronic medical records. Perspect Health Inf Manag (2010) 1.14
CD4 count at presentation for HIV care in the United States and Canada: are those over 50 years more likely to have a delayed presentation? AIDS Res Ther (2010) 1.13
HIV infection, cardiovascular disease risk factor profile, and risk for acute myocardial infarction. J Acquir Immune Defic Syndr (2015) 1.13
Health-related quality of life in veterans and nonveterans with HIV/AIDS. J Gen Intern Med (2006) 1.13
Intoxication before intercourse and risky sexual behavior in male veterans with and without human immunodeficiency virus infection. Med Care (2006) 1.13
Risk factors for tuberculosis after highly active antiretroviral therapy initiation in the United States and Canada: implications for tuberculosis screening. J Infect Dis (2011) 1.11
Heterogeneity in outcomes of treated HIV-positive patients in Europe and North America: relation with patient and cohort characteristics. Int J Epidemiol (2012) 1.11
HIV infection, aging, and immune function: implications for cancer risk and prevention. Curr Opin Oncol (2012) 1.10
Refill adherence to oral hypoglycemic agents and glycemic control in veterans. Ann Pharmacother (2010) 1.10
Alcohol consumption and depressive symptoms over time: a longitudinal study of patients with and without HIV infection. Drug Alcohol Depend (2011) 1.10
Systematic cultural adaptation of cognitive-behavioral therapy to reduce alcohol use among HIV-infected outpatients in western Kenya. AIDS Behav (2010) 1.10
Estimating alcohol content of traditional brew in Western Kenya using culturally relevant methods: the case for cost over volume. AIDS Behav (2008) 1.09
Disparities in the quality of HIV care when using US Department of Health and Human Services indicators. Clin Infect Dis (2014) 1.06
Personal health record use and its association with antiretroviral adherence: survey and medical record data from 1871 US veterans infected with HIV. AIDS Behav (2013) 1.05
Quantifying the decrement in utility from perceived side effects of combination antiretroviral therapies in patients with HIV. Value Health (2008) 1.03
HIV/AIDS, comorbidity, and alcohol: can we make a difference? Alcohol Res Health (2010) 1.02
The association between the receipt of lipid lowering therapy and HIV status among veterans who met NCEP/ATP III criteria for the receipt of lipid lowering medication. J Gen Intern Med (2009) 1.02
Receipt of opioid analgesics by HIV-infected and uninfected patients. J Gen Intern Med (2012) 1.02
Incorporating quality of evidence into decision analytic modeling. Ann Intern Med (2007) 1.01
Comparing alcohol screening measures among HIV-infected and -uninfected men. Alcohol Clin Exp Res (2012) 1.01
Hepatitis C and the risk of kidney disease and mortality in veterans with HIV. J Acquir Immune Defic Syndr (2010) 1.01
Increased risk of radiographic emphysema in HIV is associated with elevated soluble CD14 and nadir CD4. Chest (2014) 1.00
Patient-reported symptoms on the antiretroviral regimen efavirenz/emtricitabine/tenofovir. AIDS Patient Care STDS (2012) 1.00